Volitionrx (VNRX) Change in Receivables (2012 - 2025)
Volitionrx (VNRX) reported Change in Receivables of $8723.0 for Q4 2025, up 104.32% on a YoY basis from $4269.3 in Q4 2024, and down 92.7% quarter-over-quarter from $119488.0 in Q3 2025.
Volitionrx (VNRX) Change in Receivables (2012 - 2025) Analysis & Trends
Volitionrx has reported Change in Receivables for 7 years, with the latest figure at $8723.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Receivables rose 104.32% year-over-year to $8723.0; the trailing twelve-month figure through Dec 2025 stood at $207234.0 (up 256.94% YoY), and the FY2025 full-year result was $207234.0, up 256.94% from the prior year.
- Change in Receivables for Q4 2025 stood at $8723.0, down from $119488.0 in the prior quarter.
- The five-year high for Change in Receivables was $230928.0 in Q3 2023, with the low at -$315079.0 in Q2 2023.
- Historically, Change in Receivables has averaged $7986.8 across 5 years, with a median of $7139.5 in 2021.
- Annual changes were most pronounced in 2021 — Change in Receivables plunged 5783.47% — and 2023, when it surged 7805.31%.
- Volitionrx's Change in Receivables stood at -$24926.0 in 2021, then sank by 163.38% to -$65649.0 in 2022, then soared by 305.98% to $135225.0 in 2023, then plunged by 249.41% to -$202037.0 in 2024, then surged by 104.32% to $8723.0 in 2025.
- The last three Change in Receivables figures came in at $8723.0 (Q4 2025), $119488.0 (Q3 2025), and $1767.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | -124.60 Mn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -141.00 Mn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Volitionrx | 50.46 Mn | 48.00 Mn | -1.01 Mn | 8,723.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8,723.00 |
| Dec 31, 2025 | 8,723.00 |
| Sep 30, 2025 | 119,488.00 |
| Sep 30, 2025 | 119,488.00 |
| Jun 30, 2025 | 1,767.00 |
| Jun 30, 2025 | 1,767.00 |
| Mar 31, 2025 | 77,256.00 |
| Mar 31, 2025 | 77,256.00 |
| Dec 31, 2024 | -202,037.00 |
| Dec 31, 2024 | -202,037.00 |
| Sep 30, 2024 | 146,349.00 |
| Sep 30, 2024 | 146,349.00 |
| Jun 30, 2024 | 29,968.00 |
| Jun 30, 2024 | 29,968.00 |
| Mar 31, 2024 | -106,325.00 |
| Mar 31, 2024 | -106,325.00 |
| Dec 31, 2023 | 135,225.00 |
| Dec 31, 2023 | 135,225.00 |
| Sep 30, 2023 | 230,928.00 |
| Sep 30, 2023 | 230,928.00 |